2026

Case Study

Protein Ligand MD with MMPBSA: Dynamic Binding Assessment and Structural Validation Across a Diverse Target Panel

Evaluating protein-ligand MD simulation fidelity and MM(PB/GB)SA binding energy estimation accuracy across a diverse panel of ten clinically relevant drug targets

If the PDF doesn’t display, open it in a new tab or download it.

The Final Operating System of Pharma.

909.267.0577

3680 Wilshire Blvd
P04-1343 Los Angeles
CA 90010

Revilico 2026

The Final Operating System of Pharma.

909.267.0577

3680 Wilshire Blvd
P04-1343 Los Angeles
CA 90010

Revilico 2026